Prevalence and risk factors for trachoma and ocular Chlamydia trachomatis infection in Niger

British Journal of Ophthalmology

Volumn 91, Issue 1, 2007, Pages 13-17

  Abdou, A ^b   Nassirou, B ^b   Kadri, B ^b   Moussa, F ^b   Munoz, B E ^a   Opong, E ^c   West, S K ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Programme National de Lutte Contre la Cecite   (Niger)

^c World Vision International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TETRACYCLINE;

ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG FORMULATION; HUMAN; MAJOR CLINICAL STUDY; NIGER; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TRACHOMA;

AGE DISTRIBUTION; CHILD, PRESCHOOL; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; EYE INFECTIONS, BACTERIAL; FEMALE; HUMANS; HYGIENE; INFANT; MALE; NIGER; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS; RURAL HEALTH; SEX DISTRIBUTION; TRACHOMA; WATER SUPPLY;

EID: 33846190530     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2006.099507     Document Type: Article

References (32)

1. World Health Organization. Global elimination of blinding trachoma. World Health Organization 51 st World Health Assembly Resolution 51.11. Geneva: WHO, 1998.
2. Schémann JF, Sacko D, Malvy D, et al. Risk factors for trachoma in Mali. Int J Epidemiol 2002;31:194-201.
3. Thylefors B, Dawson CR, Jones BR, et al. A simple system for the assessment of trachoma and its complications. Bull World Health Organ 1987;65:477-83.
4. Schachter J, West SK, Mabey D, et al. Azithromycin in control of trachoma. Lancet 1999;354:630-5.
5. West SK, Munoz B, Mkocha H, et al. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet 2005;366:1296-300.
6. Bird M, Dawson CR, Schachter JS, et al. Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma-endemic areas? J Infect Dis 2003;187:1669-73.
7. Miller K, Schmidt G, Melese M, et al. How reliable is the clinical exam in detecting ocular chlamydial infection? Ophthalmic Epidemiol 2004;11:255-62.
8. Bailey RL, Hampton TJ, Hayes LJ, et al. Polymerase chain reaction for the detection of ocular chlamydial infection in trachoma endemic communities. J Infect Dis 1994;170:709-12.
9. Solomon AW, Holland MJ, Burton MJ, et al. Strategies for control of trachoma: observational study with quantitative PCR. Lancet 2003;362:198-204.
10. Bobo LD, Novak N, Munoz B, et al. Severe disease in children with trachoma is associated with persistent Chlamydia trachomatis infection. J Infect Dis 1997;176:1524-30.
11. Bobo LD, Munoz B, Viscidi R, et al. Diagnosis of Chlamydia trachomatis eye infection in Tanzania by polymerase chain reaction/enzyme immunoassay. Lancet 1991;338:847-50.
12. Wright HR, Taylor HR. Clinical examination and laboratory tests for estimation of trachoma prevalence in a remote setting: what are they really telling us? Lancet Infect Dis 2005;5:313-20.
13. Burton MJ, Holland MJ, Faal N, et al. Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages. Invest Ophthalmol Vis Sci 2003;44:4215-22.
14. Bailey R, Duong T, Carpenter R, et al. The duration of human ocular Chlamydia trachomatis infection is age dependent. Epidemiol Infect 1999;123:479-86.
15. West SK, Munoz B, Turner V, et al. The epidemiology of trachoma in central Tanzania. Int J Epidemiol 1991;20:1088-92.
16. Chidambaram JD, Alemayehu W, Melese W, et al. Effect of single mass antibiotic distribution on the prevalence of infectious trachoma. J Am Med Assoc 2006;295:1142-6.
17. World Health Organization. Primary health care management of trachoma. WHO/PBL/93.33. Geneva: WHO, 1993:16.
18. Moalic E, Dueymes JM, Baron R, et al. Cross-sectional survey of trachoma in school age children in the region of Thiès (Senegal). Pediatr Infect Dis J 2000;19:979-83.
19. Chalumeau BA. Prevlance de la xeroophthalmie et du trachoma chez les enfants au Senegal: enquete chez les enfants de 2 a 6 and du basin rachidien. These Docteur de Medicine, Reims 1990;28:II.
20. Zerihun N. Trachoma in Jimma zone, south western Ethiopia. Trop Med Int Health 1997;12:1115-21.
21. Emerson PM, Bailey RL, Mahdi OS, et al. Transmission ecology of the fly Musca sorbens, a putative vector of trachoma. Trans R Soc Trop Med Hyg 2000;94:28-32.
22. Taylor HR, West SK, Mmbaga BB, et al. Hygiene factors and increased risk of trachoma in central Tanzania. Arch Ophthalmol 1989;107:1821-5.
23. Cumberland P, Hailu G, Todd J. Active trachoma in children ages three to nine years in rural communities in Ethiopia: prevalence, indicators and risk factors. Trans R Soc Trop Med Hyg 2005;99:120-7.
24. Schémann JF, Guinot C, Ilboudo L, et al. Trachoma, flies and environmental factors in Burkina Faso. Trans R Soc Trop Med Hyg 2003;97:63-8.
25. Emerson PM, Lindsay SW, Walraven GEL, et al. Effect of fly control on trachoma and diarrhoea. Lancet 1999;353:1401-3.
26. West SK, Rapoza P, Munoz B, et al. Epidemiology of ocular chlamydial infection in a trachoma-hyperendemic area. J Infect Dis 1991;163:752-6.
27. Hsieh YH, Bobo LD, Quinn TC, et al. Risk factors for trachoma: 6-year follow-up of children ages 1 and 2 years. Am J Epidemiol 2000;152:204-11.
28. Alene GD, Abebe S. Prevalence of risk factors for trachoma in a rural locality of north-western Ethiopia. East Afr Med J 2000;77:308-12.
29. Bailey RL, Osmond C, Mabey DSW, et al. Analysis of the household distribution of trachoma in a Gambian village using a Monte Carlo simulation procedure. Int J Epidemiol 1989;18:644-51.
30. Wilson M, Keyvan-Laridjani E, Millan V, et al. The epidemiology of trachoma in Chiapas (Mexico). Rev Int Trachome 1987;64:159-66.
31. Courtright P, Sheppart J, Lane S, et al. Latrine ownership as a protective factor in inflammatory trachoma in Egypt. Br J Ophthalmol 1991;75:322-5.
32. West SK, Munoz B, Lynch MC, et al. Impact of face-washing on trachoma in Kongwa, Tanzania. Lancet 1995;345:155-8.